We pick through the latest results from two of AIM’s world leaders. The shares of both have struggled to advance over recent years but, with plenty of investment of late and valuations compelling, they look well-placed to deliver. (Premium)
Client portfolios managed by our associates, Fundamental Asset Management, may hold shares in companies covered below Advanced Medical: will it start to deliver? Advanced Medical Solutions (AIM: AMS), a world-leading specialist in tissue-healing technologies, announced results for the year ended 31 December 2023. AMS has a wide range of surgical products including tissue adhesives, sutures, haemostats, internal fixation devices , bone substitutes and internal sealants, which it markets under its brands LiquiBand®, RESORBA®, LiquiBandFix8®, LIQUIFIXTM and SEAL-G®. It also supplies wound care dressings through its ActivHeal® brand as well as under white label arragements. Since 2019, the Group has made…
Sign up and read the full article
Register to continue reading our content.
Get FREE access now
Already a member? Login